ACRO Launching New Video Series With Health Coalition Leaders
The Association of Clinical Research Organizations is introducing a new series of videos featuring the leaders of prominent healthcare interest groups.
The first two videos feature Ladd Wiley, Executive Director of the Alliance for a Stronger FDA, and Michael Reilly, Executive Director of the Alliance for Safe Biologic Medicines.
“ACRO participates in several alliances and coalitions to help amplify our message about the importance of clinical research,” said John Lewis, Vice President of Public Affairs. “We thank Ladd and Michael for helping us kick-off this series by discussing the important topics of adequate funding for the FDA and regulatory matters surrounding biosimilars. We plan several additional videos covering issues such as incentives for medical research, regenerative medicine, comparative effectiveness research and the business environment for life sciences in India.”
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
